Abstract
<div>Abstract<p><b>Purpose:</b> Gastric carcinomas are heterogeneous, and the current therapy remains essentially based on surgery with conventional chemotherapy and radiotherapy. This study aimed to characterize biomarkers allowing the detection of cancer stem cells (CSC) in human gastric carcinoma of different histologic types.</p><p><b>Experimental Design:</b> The primary tumors from 37 patients with intestinal- or diffuse-type noncardia gastric carcinoma were studied, and patient-derived tumor xenograft (PDX) models in immunodeficient mice were developed. The expressions of 10 putative cell surface markers of CSCs, as well as aldehyde dehydrogenase (ALDH) activity, were studied, and the tumorigenic properties of cells were evaluated by <i>in vitro</i> tumorsphere assays and <i>in vivo</i> xenografts by limiting dilution assays.</p><p><b>Results:</b> We found that a subpopulation of gastric carcinoma cells expressing EPCAM, CD133, CD166, CD44, and a high ALDH activity presented the properties to generate new heterogeneous tumorspheres <i>in vitro</i> and tumors <i>in vivo</i>. CD44 and CD166 were coexpressed, representing 6.1% to 37.5% of the cells; ALDH activity was detected in 1.6% to 15.4% of the cells; and the ALDH<sup>+</sup> cells represented a core within the CD44<sup>+</sup>/CD166<sup>+</sup> subpopulation that contained the highest frequency of tumorigenic CSCs <i>in vivo</i>. The ALDH<sup>+</sup> cells possessed drug efflux properties and were more resistant to standard chemotherapy than the ALDH<sup>−</sup> cells, a process that was partially reversed by verapamil treatment.</p><p><b>Conclusions:</b> CD44 and ALDH are the most specific biomarkers to detect and isolate tumorigenic and chemoresistant gastric CSCs in noncardia gastric carcinomas independently of the histologic classification of the tumor. <i>Clin Cancer Res; 23(6); 1586–97. ©2016 AACR</i>.</p></div>
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
